AVITA Medical (RCEL) Work In Process (2021 - 2022)
AVITA Medical (RCEL) reported Work In Process of $384000.0 for Q4 2022, up 118.18% on a YoY basis from $176000.0 in Q4 2021, and up 118.18% quarter-over-quarter from $176000.0 in Q4 2021.
AVITA Medical (RCEL) Work In Process (2021 - 2022) Analysis & Trends
AVITA Medical has reported Work In Process for 2 years, with the latest figure at $384000.0 in Q4 2022.
- For the quarter ending Q4 2022, Work In Process rose 118.18% year-over-year to $384000.0; the trailing twelve-month figure through Dec 2022 stood at $384000.0 (up 118.18% YoY), and the FY2022 full-year result was $384000.0, up 118.18% from the prior year.
- Work In Process for Q4 2022 stood at $384000.0, up from $176000.0 in the prior quarter.
- The five-year high for Work In Process was $384000.0 in Q4 2022, with the low at $176000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | AVITA Medical | 109.91 Mn | 91.73 Mn | 14.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 384,000.00 |
| Dec 31, 2021 | 176,000.00 |
| Jun 30, 2021 | 241,000.00 |